Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue European Journal of Endocrinology Année : 2022

Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline

Résumé

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with significant autoimmune endocrinopathies that pose both diagnostic and treatment challenges. The aim of this guideline is to provide clinicians with the best possible evidence-based recommendations for treatment and follow-up of patients with ICI-induced endocrine side-effects based on the Grading of Recommendations Assessment, Development, and Evaluation system. As these drugs have been used for a relatively short time, large systematic investigations are scarce. A systematic approach to diagnosis, treatment, and follow-up is needed, including baseline tests of endocrine function before each treatment cycle. We conclude that there is no clear evidence for the benefit of high-dose glucocorticoids to treat endocrine toxicities with the possible exceptions of severe thyroid eye disease and hypophysitis affecting the visual apparatus. With the exception of thyroiditis, most endocrine dysfunctions appear to be permanent regardless of ICI discontinuation. Thus, the development of endocrinopathies does not dictate a need to stop ICI treatment.
Fichier principal
Vignette du fichier
1479-683X-EJE-22-0689.pdf (1.89 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY - Paternité

Dates et versions

hal-04039446 , version 1 (21-03-2023)

Licence

Paternité

Identifiants

Citer

Eystein Husebye, Frederik Castinetti, Sherwin Criseno, Giuseppe Curigliano, Brigitte Decallonne, et al.. Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. European Journal of Endocrinology, 2022, 187 (6), pp.G1-G21. ⟨10.1530/EJE-22-0689⟩. ⟨hal-04039446⟩

Collections

UNIV-AMU MMG
19 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More